Overview of HBV associated HBV-HIV Coinfection

ID Literature Title Group
1 20655563 HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing
Mutation
2 20944991 Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil
Mutation
3 21671883 Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment
Mutation
4 21685546 HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain
Mutation
5 21915864 Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B
Mutation
6 22156858 Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy
Mutation
7 22166560 Prevalence and resistance pattern of genotype G and H in chronic hepatitis B and HIV co-infected patients in Mexico
Mutation
8 22195774 Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Mutation
9 22422696 The perils of relying on anti-hepatitis B total core antibody in screening individuals infected with HIV
Mutation
10 22459735 Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape
Mutation
11 22860080 Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand
Mutation
12 22930502 Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi
Mutation
13 23029487 Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa
Mutation
14 23465393 Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients
Mutation
15 23487374 Prophylactic effect of antiretroviral therapy on hepatitis B virus infection
Mutation
16 23497042 Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study
Mutation
17 23892239 HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes
Mutation
18 23925707 Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV
Mutation
19 24444423 Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-Hepatitis B core antibodies
Mutation
20 24587360 Molecular characterization of HBV strains circulating among the treatment-naive HIV/HBV co-infected patients of eastern India
Mutation
21 24700252 HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study
Mutation
22 24915064 Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study
Mutation
23 25449246 Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan
Mutation
24 25462190 Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominance
Mutation
25 25654813 High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy
Mutation
26 25786446 Hepatitis B e antigen and hepatitis B surface antigen seroclearance with the emergence of lamivudine-associated and core mutations following CD4 elevation in a patient with hepatitis B and HIV
Mutation
27 25852125 Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Cote d'Ivoire
Mutation
28 26386408 Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy
Mutation
29 26419862 High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians
Mutation
30 26764909 Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon
Mutation
31 26890489 Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans
Mutation
32 27061406 Overt and occult hepatitis B virus infection among treatment-naive HIV-infected patients in Brazil
Mutation
33 27245734 Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lome, Togo: Prevalence and molecular consequences
Mutation
34 27354181 HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia
Mutation
35 27381922 HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg
Mutation
36 27769271 Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon
Mutation
37 28376292 Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians
Mutation
38 29315352 Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence
Mutation
39 29408943 Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia
Mutation
40 29660214 Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa
Mutation
41 29948380 BCP/PC mutation prevalence and their association with HBV replication in HIV/HBV co-infected patients
Mutation
42 30257068 Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa
Mutation
43 30368502 High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China
Mutation
44 30382563 Molecular characterization of hepatitis B virus in blood donors in Botswana
Mutation
45 31566576 High frequency of drug resistance mutations in the HBV genome in ART-experienced HIV-coinfected patients in southwestern Nigeria
Mutation
46 31622056 [Identification and molecular-genetic characteristics of the hepatitis B virus among HIV-infected patients in Arkhangelsk.]
Mutation
47 32545313 Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
Mutation
48 32915862 Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia
Mutation
49 33245644 Optimization of the algorithm diagnosis chronic hepatitis B markers in patients with newly diagnosed HIV infection
Mutation
50 33446224 Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria
Mutation
51 33821807 Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort Study
Mutation
52 35380862 Comparative analysis of HBV basic core promoter/pre-core gene mutations and viral quasispecies diversity in HIV/HBV co-infected and HBV mono-infected patients
Mutation
53 35454370 Hepatitis B Virus Genotypes and Antiviral Resistance Mutations in Romanian HIV-HBV Co-Infected Patients
Mutation
54 37555061 High frequency of Lamivudine and Telbivudine resistance mutations in hepatitis B virus isolates from human immunodeficiency virus co-infected patients on highly active antiretroviral therapy in Bucaramanga, Colombia
Mutation
55 38675933 High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana
Mutation
56 39043430 Hepatitis B Virus Reactivation after Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody
Mutation
57 39062134 Molecular Characterization of Hepatitis B Virus in People Living with HIV in Rural and Peri-Urban Communities in Botswana
Mutation
58 39413542 Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection
Mutation
59 39676181 Comparison of Basal Core Promoter Region Mutation and Precore Mutation among Monoinfected Hepatitis B Virus and Coinfected Hepatitis B Virus with Human Immunodeficiency Virus Patients
Mutation
60 19800842 Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study
Mutation
61 26390290 Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
Mutation
62 12368144 [Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients]
Mutation
63 10449493 Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus
Mutation
64 10679599 [Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients]
Mutation
65 10894274 Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR co-ordinating committee
Mutation
66 12853747 Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals
Mutation
67 14760897 Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay
Mutation
68 15259898 In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir
Mutation
69 15339340 Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
Mutation
70 15577546 Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment
Mutation
71 16218172 Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir
Mutation
72 16549970 Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
Mutation
73 16801428 Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus
Mutation
74 17086064 A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient
Mutation
75 17224847 Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients
Mutation
76 17506609 Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B
Mutation
77 18167643 Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity
Mutation
78 18453854 The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients
Mutation
79 18572746 Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV
Mutation
80 18624719 Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters
Mutation
81 19098499 Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient
Mutation
82 19178592 Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations
Mutation
83 19301976 Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients
Mutation
84 19475624 Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B
Mutation
85 19889143 Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals
Mutation
86 19946588 Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report
Mutation
87 20631103 Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana
Mutation
88 20648600 High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B
Mutation
Contents
Description
Disease Group Note
  • The label in Group indicates that the disease is mentioned in mutation or integration research. Click the eye label to view the corresponding module information.